This work, describing siRNA targeting FXIII-B (siFXIIIB), is the first pharmacologic approach for long-acting, reversible,…
eabramovichAugust 7, 2020
AbCellera today announced that LY-CoV555, a human antibody discovered by AbCellera in collaboration with the…
eabramovichAugust 6, 2020
In some Huntington disease (HD) patients, the “loss of interruption” (LOI) variant eliminates an interrupting…
eabramovichAugust 6, 2020
In her most recent Forward Thinking post, Dr. Bev Holmes unpacked what it means to be a…
eabramovichAugust 5, 2020
To say that the past few months have been “challenging” would be a hefty understatement.…
sciencecityAugust 4, 2020
Ovarian cancer, the fifth most common cause of cancer death in Canadian women, has several subtypes,…
sciencecityAugust 4, 2020
Katlyn Richardson is one of five Vancouver Coastal Health Research Institute trainees who have received…
eabramovichAugust 3, 2020
